Enveric Biosciences, Inc. (ENVB) › Cash & EquivalentsEnveric Biosciences, Inc. (ENVB) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $1.8K2010: $1.1K2011: $18.2K2012: $1.4K2013: $2492014: $5.1K2015: $1.88M2016: $1.38M2017: $4.88M2018: $1.37M2019: $431.4K$431.4K2009Cash & Equivalents (USD)2019Fiscal YearCash & EquivalentsChange YoY2019$431.4K-68.5%2018$1.37M-71.9%2017$4.88M+253.8%2016$1.38M-26.5%2015$1.88M+36832.8%2014$5.1K+1942.2%2013$249-82.0%2012$1.4K-92.4%2011$18.2K+1519.1%2010$1.1K-37.2%2009$1.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share